Skip to main content
Clinical Trials/NCT05979493
NCT05979493
Recruiting
Phase 4

Quadratus Lumborum Block to Improve Postoperative Pain Management After Laparoscopic Myomectomies: a Double-blinded and Prospective Randomized Clinical Trial.

Joseph Findley MD1 site in 1 country80 target enrollmentAugust 24, 2024

Overview

Phase
Phase 4
Intervention
Bupivacain
Conditions
Postoperative Pain
Sponsor
Joseph Findley MD
Enrollment
80
Locations
1
Primary Endpoint
Total number of doses of rescue analgesics given as measured by medical chart review
Status
Recruiting
Last Updated
8 months ago

Overview

Brief Summary

This study aims to determine the efficacy of a quadratus lumborum (QL) block in decreasing postoperative pain in patients undergoing myomectomy for uterine fibroids. A QL block is a temporary anesthetic injection in the quadratus lumborum muscle, a muscle in the lower back, that has been previously shown to significantly reduce postoperative pain levels in patients undergoing abdominal and pelvic surgery. Because of its demonstrated effects, the QL block is becoming a standard of anesthesia and surgical care. Since participants will be undergoing a myomectomy procedure, the investigators believe that participants may qualify to participate in this study. The investigators will be comparing patients who receive the QL block (in addition to standard anesthesia and postoperative pain care) with patients who do not receive the QL block (in addition to standard care). The participants will be randomly assigned to one of the two groups and may or may not actually receive the block.

Registry
clinicaltrials.gov
Start Date
August 24, 2024
End Date
July 3, 2026
Last Updated
8 months ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
Joseph Findley MD
Responsible Party
Sponsor Investigator
Principal Investigator

Joseph Findley MD

University Hospitals Department of Reproductive Endocrinology and Infertility

University Hospitals Cleveland Medical Center

Eligibility Criteria

Inclusion Criteria

  • Presence of uterine fibroids requiring surgical excision with preservation of the uterus
  • Stated willingness to comply with all study procedures and availability for the duration of the study
  • Provision of signed and dated informed consent form

Exclusion Criteria

  • Pre-existing diagnoses of anxiety or depression
  • Pre-existing coagulopathies
  • Pre-existing neuropathic or chronic pelvic pain
  • Chronic opioid use
  • Illiteracy due to inability to read and understand plain questionnaire
  • Non-English speaking

Arms & Interventions

QL Block with Bupivacaine

Participants will get a QL block using 30cc Bupivacaine bilaterally in quadratus lumborum muscle (60cc total).

Intervention: Bupivacain

Control

Participants will get a sham injection of 30cc saline bilaterally in quadratus lumborum muscle (60cc total).

Intervention: Saline

Outcomes

Primary Outcomes

Total number of doses of rescue analgesics given as measured by medical chart review

Time Frame: Up to 24 hours

Time in minutes from first analgesic request as measured by medical chart review

Time Frame: Up to 24 hours

Secondary Outcomes

  • Patient satisfaction with perioperative pain management measured on a scale of 1-10(Up to 48 hours after discharge from hospital.)
  • Pain as measured by visual analog scale (VAS)(Up to 48 hours after discharge from hospital.)

Study Sites (1)

Loading locations...

Similar Trials